The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Alkermes plc(NASDAQ:ALKS) 
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA (aripiprazole lauroxil), an e...
Website: http://www.alkermes.com
Founded: 1987
Full Time Employees: 2,235
Sector: Healthcare
Industry: Biotechnology
Alkermes plc Days Payable Outstanding ttm (DPO)
Alkermes plc Days Receivable Outstanding ttm (DSO)
Alkermes plc Days Inventory Outstanding ttm (DIO)
Alkermes plc Op Cashflow Per Share ttm
Alkermes plc Free Cashflow Per Share ttm
Alkermes plc Cash Per Share ttm
Alkermes plc P/S ratio ttm
Alkermes plc (GAAP) P/E ratio ttm
Alkermes plc P/B ratio ttm
No extra charts and metrics for this ticker.